Akut limfoid leukémia (ALL): vizsgálatok itt: Puerto Rico
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleInotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Where
- San Juan
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03739814 - 2. fázisTaking peopleA Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- San Juan
- Életkor
- 366 nap to 46 év
- People
- 222 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06124157 - 2. fázisTaking peopleTesting the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Where
- San Juan
- Életkor
- Up to 365 nap
- People
- 153 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06317662 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- San Juan
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 2. fázisTaking peopleA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- San Juan
- Életkor
- 1 év to 30 év
- People
- 461 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04546399 - 3. fázisTaking peopleInotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Where
- Caguas, San Juan
- Életkor
- 365 nap to 25 év
- People
- 5951 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03959085 - 1/2. fázisTaking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Caguas, San Juan
- Életkor
- Up to 22 év
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - No phaseTaking peopleEffects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Where
- San Juan
- People
- 420 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT01790152